REPURCHASE OF SHARES IN ASTRAZENECA PLC

2/16/2012 7:25 AM EST

AstraZeneca PLC announced that, on 15 February 2012, it purchased for cancellation 400,000 ordinary shares of AstraZeneca PLC at a price of 2900 pence per share. Upon the cancellation of these shares, the number of shares in issue will be 1,278,929,353.

A C N Kemp

Company Secretary

16 February 2012

AstraZeneca

RSS

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, ...

CONTACT

AstraZeneca
08-553 260 00
http://www.astrazeneca.se

Anna Carbin-Åhlund - Press Contact
+468-553 269 39

Recent Releases

ASTRAZENECA APPOINTS MARC DUNOYER AS EXECUTIVE VICE PRESIDENT, GLOBAL PORTFOLIO & PRODUCT STRATEGY
3/21/2013 8:43 AM EST
ASTRAZENECA OUTLINES STRATEGY TO RETURN TO GROWTH AND ACHIEVE SCIENTIFIC LEADERSHIP
3/21/2013 3:02 AM EST
SECOND QUARTER AND HALF YEAR RESULTS 2012
7/26/2012 2:01 AM EST
BRISTOL-MYERS SQUIBB AND ASTRAZENECA EXPAND DIABETES ALLIANCE THROUGH BRISTOL-MYERS SQUIBB’S ACQUISITION OF AMYLIN PHARMACEUTICALS
7/2/2012 2:26 AM EST
ASTRAZENECA AND MERCK AGREE TO AMEND SECOND OPTION
6/27/2012 7:09 AM EST

REPURCHASE OF SHARES IN ASTRAZENECA PLC

AstraZeneca

Recent Releases

Tags